Skip to content

Comparison of the efficacy of 595nm pulsed dye laser with different endpoint reactions in treating facial telangiectasia

Comparison of the efficacy of 595nm pulsed dye laser with different endpoint reactions in treating facial telangiectasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129673
Enrollment
Unknown
Registered
2026-08-07
Start date
2023-10-18
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Telangiectasia

Interventions

Purpura:Pulsed dye laser treatment for half face with purpura as the endpoint reaction
Sub-purpura:Pulsed dye laser treatment for the other half face with sub-purpura as the endpoint reaction

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with facial telangiectasia 2. Age range: 18-60 years old 3. Obtain informed consent from the subjects

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the inclusion criteria for combining other facial symptoms 2. Pregnant or lactating women 3. Individuals who are allergic to light within the wavelength range of approximately 595nm 4. Individuals who have been using retinoic acid drugs for the past 6 months 5. Epilepsy patients 6. Patients with other serious organic or systemic diseases 7. Other situations deemed unsuitable by researchers to accept 595nm pulsed dye lasers.

Design outcomes

Primary

MeasureTime frame
Skin Physiology Test - Erythema Index;Skin Physiology Test - Transepidermal Water Loss;Physician evaluation of the severity of erythema on both cheeks;Physician evaluation of the severity of post-inflammatory hyperpigmentation on both cheeks;

Secondary

MeasureTime frame
Subjective evaluation of downtime;Subjective evaluation of satisfaction;Subjective evaluation of preference;

Countries

China

Contacts

Public ContactZhang Wei

Shanghai Skin Disease Hospital

zw5259@163.com+86 21 3680 3126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026